SentiSense
Ctrl+K
Quick tip: Press
to search stocks
L
LLY
Eli Lilly and Company
$990.33
+7.07 (+0.72%)
Summary
Stories
News
Metrics
Fundamentals
Drag to measure
Stock Reports
Upgrade to access stock reports prepared by our team with the help of AI.
What's Included
Curated Bull & Bear Case Analysis
Data-Driven Investment Perspectives
Quantified Risks & Catalysts
Expert-Curated Financial Research
Company Profile
Symbol
LLY
Market Cap
$884.36B
IPO Date
Jul 9, 1970
CEO
--
Employees
50,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Read MoreSimilar Stocks
AMGN
Amgen Inc.
$369.53
+0.53%
VRTX
Vertex Pharmaceuticals Incorporated
$456.69
-0.90%